id,subject,predicate,object,props
anagliptin_treats_t2d,CHEBI:136043,biolink:treats,MONDO:0005148,"{\"fda_approved\": false}"
bezafibrate_treats_t2d,CHEBI:47612,biolink:treats,MONDO:0005148,"{\"fda_approved\": false}"
bezafibrate_treats_obesity,CHEBI:47612,biolink:treats,MONDO:0011122,"{\"fda_approved\": false}"
metformin_treats_t2d,CHEBI:6801,biolink:treats,MONDO:0005148,"{\"fda_approved\": true}"
metformin_treats_obesity,CHEBI:6801,biolink:treats,MONDO:0011122,"{}"
t2d_has_phenotype_increased_weight,MONDO:0005148,biolink:has_phenotype,HP:0004324,"{}"
t2d_has_phenotype_albuminaria,MONDO:0005148,biolink:has_phenotype,HP:0012592,"{}"
obesity_has_phenotype_increased_weight,MONDO:0011122,biolink:has_phenotype,HP:0004324,"{}"
CASP3_molecularly_interacts_with_CASP8,NCBIGene:836,biolink:molecularly_interacts_with,NCBIGene:841,"{}"
metformin_increases_expression_of_CASP8,CHEBI:6801,biolink:increases_expression_of,NCBIGene:841,"{}"
metformin_increases_expression_of_CASP3,CHEBI:6801,biolink:increases_expression_of,NCBIGene:836,"{}"
t2d_associated_with_CASP8,MONDO:0005148,biolink:genetic_association,NCBIGene:841,"{}"
t2d_associated_with_CASP3,MONDO:0005148,biolink:genetic_association,NCBIGene:836,"{}"
obesity_ga_CASP3,MONDO:0011122,biolink:genetic_association,NCBIGene:836,"{}"
metformin_treats_carcinoma,CHEBI:6801,biolink:treats,MONDO:0004993,"{}"
carcinoma_associated_with_CASP8,MONDO:0004993,biolink:genetic_association,NCBIGene:841,"{}"
carcinoma_associated_with_BRCA1,MONDO:0004993,biolink:condition_associated_with_gene,NCBIGene:672,"{}"